IRIDEX CFO receives stock and option grants

IRIDEX CORP awarded its Chief Financial Officer, Romeo R. Dizon, equity-based compensation consisting of 30,000 restricted stock units (RSUs) and a stock option for 170,000 shares.

Rhea-AI Filing Summary

IRIDEX CORP awarded its Chief Financial Officer, Romeo R. Dizon, equity-based compensation consisting of 30,000 restricted stock units (RSUs) and a stock option for 170,000 shares. Each RSU represents a contingent right to receive one share of common stock, vesting in three equal annual installments: one-third on July 10, 2027 and one-third on each of the next two anniversaries, subject to his continued service.

The option gives Dizon the right to purchase up to 170,000 shares of IRIDEX common stock at an exercise price of $1.10 per share and expires on July 10, 2033. Following these awards, he holds 163,284 shares of common stock directly, in addition to the newly granted stock option. These are compensation grants rather than open‑market purchases or sales.

Insider Trade Summary

Grant/Award: 200,000 shares

Grant/Award 2 txns

Insider Dizon Romeo R

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock option (right to buy) F2	170,000	$0.00	$0.00
Grant/Award	Common Stock F1	30,000	$0.00	$0.00

Holdings After Transaction: Stock option (right to buy) — 170,000 contracts (Direct); Common Stock — 163,284 shares (Direct)

Footnotes (2)

1. F1. Each share is represented by a restricted stock unit (RSU). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vest as to one-third of the shares on July 10, 2027 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.
2. F2. The option vests as to one-third of the Shares on July 10, 2027 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.

Key Figures

RSU grant to CFO: 30,000 RSUs Stock options granted: 170,000 options Option exercise price: $1.10 per share +2 more

5 metrics

RSU grant to CFO 30,000 RSUs Equity award to CFO Romeo R. Dizon on July 10, 2026

Stock options granted 170,000 options Right to buy IRIDEX common stock granted July 10, 2026

Option exercise price $1.10 per share Exercise price for the 170,000-share option award expiring July 10, 2033

Post-award common shares held 163,284 shares Common stock held directly by Romeo R. Dizon after the RSU award

Option expiration date July 10, 2033 Expiration of the 170,000-share stock option granted to the CFO

Key Terms

restricted stock unit (RSU), Stock option (right to buy), exercise price, service provider

4 terms

restricted stock unit (RSU) financial

"Each share is represented by a restricted stock unit (RSU)."

A restricted stock unit (RSU) is a promise from a company to give an employee company shares (or cash equal to their value) at a future date if certain conditions are met, such as staying with the company or hitting performance targets. For investors, RSUs matter because when they convert into actual shares they increase the number of shares available and can create selling pressure as employees cash out—think of them as a future paycheck paid in company stock.

Stock option (right to buy) financial

""Stock option (right to buy)" is listed as a derivative security."

exercise price financial

"conversion_or_exercise_price is shown as 1.1000 per share."

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

service provider financial

"subject to the Reporting Person continuing as a service provider."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did IRIDEX (IRIX) grant to CFO Romeo R. Dizon?

IRIDEX granted CFO Romeo R. Dizon 30,000 RSUs and a stock option covering 170,000 shares. The RSUs each represent one share of common stock, while the option allows him to buy shares at a fixed $1.10 exercise price.

How do the new RSUs for IRIDEX (IRIX) CFO Romeo Dizon vest?

The 30,000 RSUs vest in three equal installments. One-third vests on July 10, 2027, and one-third vests on each of the next two yearly anniversaries, provided Dizon continues as a service provider through each vesting date.

What are the key terms of Romeo Dizon’s new IRIDEX (IRIX) stock options?

Dizon received options for 170,000 shares of IRIDEX common stock with a $1.10 exercise price, expiring on July 10, 2033. The options vest one-third on July 10, 2027 and one-third on each of the following two anniversaries, subject to continued service.

How many IRIDEX (IRIX) shares does CFO Romeo Dizon hold after these grants?

After the reported awards, Romeo R. Dizon directly holds 163,284 shares of IRIDEX common stock. This figure reflects his common stock position following the 30,000 RSU grant, separate from the new option covering 170,000 shares.

Were Romeo Dizon’s IRIDEX (IRIX) transactions open-market trades or compensation grants?

The transactions were compensation grants, not open-market trades. Both the 30,000 RSUs and the 170,000-share stock option are coded as awards, with no reported purchases or sales of IRIDEX shares in the open market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/14/2026 - 04:38 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dizon Romeo R

(Last) (First) (Middle)

1212 TERRA BELLA AVENUE

(Street)

MOUNTAIN VIEW CALIFORNIA 94043

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
IRIDEX CORP [ IRIX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/10/2026		A		30,000(1)	A	$0	163,284	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock option (right to buy)	$1.1	07/10/2026		A		170,000		(2)	07/10/2033	Common Stock	170,000	$0	170,000	D

Explanation of Responses:

1. Each share is represented by a restricted stock unit (RSU). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vest as to one-third of the shares on July 10, 2027 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.

2. The option vests as to one-third of the Shares on July 10, 2027 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.

	/s/ Nilo De Castro, Attorney-in-fact for Romeo R. Dizon	07/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)